New

Organophosphates Poisoning

Organophosphates Poisoning


ORGANOPHOSPHATES

  • Highly popular insecticides because they are effective, disintegrate within days of application & do not persist in the environment
  • Even minute quantities can penetrate the skin & be lethal, as evidenced by the use of organophosphate nerve gases sarin, soman, tabun, & VX in chemical weapons.

ORGANOPHOSPHORUS POISONS

  •  Esters of phosphoric acid 2 series of compounds
  1. ALKYL PHOSPHATES
  2. ARYL PHOSPHATES
Alkyl phosphates are:
  • HETP
  • TEPP (Tetron)
  • OMPA
  • Dimefox
  • Isopestox
  • Malathion (Kill bug; Bugsolin)
  • Sulfotepp
  • Demeton
  • Trichlorfon
Aryl phosphates are:
  • Parathion (nitrostigmine) (Follodol; Kill phos; Ekato)
  • Paraoxon
  • Methyl-parathion (Metacide)
  • Chlorthion
  • Diazinon (Diazion; Tik 20)

 Pathophysiology

  • The organophosphates irreversibly inhibit acetylcholinesterase, resulting in an overabundance of acetylcholine at synapses & the myoneural junction.
  • The acetylcholine initially excites & then paralyzes the CNS, the parasympathetic nerve endings & the sweat glands (muscarinic effects), somatic nerves & ganglionic synapses of autonomic ganglia (nicotinic effects).

 SIGNS AND SYMPTOMS

  • Occur when Achestrase levels drop to 30% of its normal activity
  • Ocular exposure — persistent miosis
  • Onset of systemic symptoms varies with different routes of absorption
  • Involuntary Ms + secretory glands are affected first followed by voluntary Ms then brain functions
  • Symptoms may begin within 5 min to 2 hrs  And are max in 24 hrs
  • Resp. and G.I.T symptoms are more marked depending on the route of entry

 MUSCARINIC MANIFESTATIONS

  • Salivation
  • Lacrimation
  • Urination
  • Defaecation
  • Distress
  • Emesis
  • Diaphoresis, diarrhoea,
  • Miosis
  • Bronchorrhea, bronchospasm
  • C.V.S: Bradycardia, hypotension
  • Ciliary Body: Blurred vision
  • Bladder : Urinary incontinence

NICOTINIC MANIFESTATIONS

  • STRIATED MUSCLE: Initial stimulus results in contraction, later there is paralysis due to persistent depolarization
  • Ms weakness is due to accumulation of Ach which causes fasciculation, cramps, weakness , areflexia

SYMPATHETIC GANGLIA

  • HT, Tachycardia, pallor, mydriasis

 CNS MANIFESTATIONS

  • Restlessness, emotional lability, headache, tremor, drowsiness, confusion, slurred speech, ataxia, generalised weakness, coma, convulsion,depression of respiration and CVS centres 

 Severe poisoning:

  • SLUDGE and respiratory insufficiency, weakness, fasciculations, coma, paralysis, seizure, autonomic dysfunction.
  • Porphyrinemia resulting in CHROMOLACHRYORRHOEA (shedding of red tears) due to accumulation of porphyrin in the lacrimal glands is seen very rarely

Paralysis due to organophosphate (OP) poisoning can be three types 

Type I (cholinergic phase)

  • Involves acute paralysis secondary to persistent depolarization at the neuromuscular junction caused by persistent stimulation by excessive Ach.
  • Treatment- Atropine with or without oximes

Type II(intermediate syndrome.)

  • It develops 1-4 days after resolution of acute cholinergic symptoms.
  • It is manifested as paralysis and respiratory distress.
  • It involves proximal muscles with relative sparing of distal muscle groups.
  • The pathogenesis presumed to be dysfunction of neuromuscular junction caused by down regulation of presynaptic and postsynaptic nicotinic receptors due to release of excessive Ach and Ca’ respectively.
  • Atropine is ineffective, symptomatic treatment is given

 

Type III(OP-induced delayed polyneuropathy (OPIDN))

  • It occurs 1-3 weeks after exposure and is associated with demyelination of axons.
  • It is not caused by cholinesterase inhibition but rather by neuropathy target esterase (NTE) inhibition.
  • It involves distal muscles with relative sparing of neck muscles, cranial nerves, and proximal muscles.

 DIAGNOSIS

  • 5 ml of heparinised blood for cholinesterase determination
  • The cholinesterase activity of blood and plasma fall by 22 to 88%.
  • The avg normal values are 77 to 142 in the RBC’s and 41 to 142 in the plasma
  • Diagnosis may be confirmed by giving 2 mg of atropine.
  • A 25% reduction in red blood cell cholinesterase confirms organophosphate poisoning.

TREATMENT

  • Establishing an airway & ensuring proper ventilatory support, cardiac monitoring;
  • Gastric Lavage with 1:5000 KMnO4
  • Activated Charcoal one gm/kg
  • Atropine sulphate arrests the muscarinic and CNS symptoms. It has no effects on the nicotinic symptoms
  • 2-4 mg of atropine is given i.v as a test dose
  • If no effect this dose is doubled every 5-10 min until secretions are controlled, the skin is dr./ and there is sinus tachycardia.
  • An avg patient requires 40 mg per day but upto 1000mg /day have been used’
  • Atropine is the mainstay of treatment (antidote of choice).
  • Cholinesterase regenerator compounds (oximes)
  • Pralidoxime is most commonly used oxime.
  • They antagonize only peripheral effects, but not central effects except for diacetylmonoxime (DAM) which crosses BBB and antagonizes central effects also.·  
Exam Question
 

ORGANOPHOSPHORUS POISONS

  1.  ALKYL PHOSPHATES
  2.  ARYL PHOSPHATES
Alkyl phosphates are:
  • HETP
  • TEPP (Tetron)
  • OMPA
  • Dimefox
  • Isopestox
  • Malathion (Kill bug; Bugsolin)
  • Sulfotepp
  • Demeton
  • Trichlorfon
Aryl phosphates are:
  • Parathion (nitrostigmine) (Follodol; Kill phos; Ekato)
  • Paraoxon
  • Methyl-parathion (Metacide)
  • Chlorthion
  • Diazinon (Diazion; Tik 20)

 Pathophysiology

  • The organophosphates irreversibly inhibit acetylcholinesterase, resulting in an overabundance of acetylcholine at synapses & the myoneural junction.

 MUSCARINIC MANIFESTATIONS

  • Salivation
  • Lacrimation
  • Urination
  • Defaecation
  • Distress
  • Emesis
  • Diaphoresis, diarrhoea,
  • Miosis
  • Bronchorrhea, bronchospasm
  • C.V.S: Bradycardia, hypotension
  • Ciliary Body: Blurred vision
  • Bladder : Urinary incontinence

 CNS MANIFESTATIONS

  • Restlessness, emotional lability, headache, tremor, drowsiness, confusion, slurred speech, ataxia, generalised weakness, coma, convulsion, depression of respiration and CVS centres 

 Severe poisoning:

  • Porphyrinemia resulting in CHROMOLACHRYORRHOEA (shedding of red tears) due to accumulation of porphyrin in the lacrimal glands is seen very rarely

Paralysis due to organophosphate (OP) poisoning can be three types 

Type I (cholinergic phase)

  • Involves acute paralysis secondary to persistent depolarization at the neuromuscular junction caused by persistent stimulation by excessive Ach.
  • Treatment- Atropine with or without oximes

Type II(intermediate syndrome.)

  • It develops 1-4 days after resolution of acute cholinergic symptoms.
  • It is manifested as paralysis and respiratory distress.
  • Atropine is ineffective, symptomatic treatment is given

 

Type III(OP-induced delayed polyneuropathy (OPIDN))

  • It occurs 1-3 weeks after exposure and is associated with demyelination of axons.

 DIAGNOSIS

  •  The cholinesterase activity of blood and plasma fall by 22 to 88%..

TREATMENT

  • Activated Charcoal one gm/kg
  • Atropine sulphate arrests the muscarinic and CNS symptoms. It has no effects on the nicotinic symptoms
  • 2-4 mg of atropine is given i.v as a test dose
  • If no effect this dose is doubled every 5-10 min until secretions are controlled, the skin is dr./ and there is sinus tachycardia.
  • Atropine is the mainstay of treatment (antidote of choice).
  • Pralidoxime is most commonly used oxime.
Don’t Forget to Solve all the previous Year Question asked on Organophosphates Poisoning

Exit mobile version